Press "Enter" to skip to content

From a Nobel Prize to fighting a rare disease | Victor Ambros on genes, medicine, and Poland

What happens after a scientist wins the Nobel Prize? For Victor Ambros, it means continuing the fight to turn scientific discovery into real treatments.

In this interview with TVP World, the Nobel Prize–winning biologist discusses his groundbreaking discovery of microRNA, a key breakthrough that transformed our understanding of gene regulation and modern genetic medicine.

Ambros is visiting Poland to support AGO Alliance Poland, a non-profit organization working to advance research into AGO syndrome — an ultra-rare genetic condition caused by mutations in the Ago1 and Ago2 genes. The organization raises awareness and supports children and families living with this rare disorder.

In this conversation, Ambros explains:
• how the discovery of microRNA changed biology
• the future of RNA-based medicine and gene therapy
• why rare disease research is one of the biggest challenges in medicine
• the promise of technologies like CRISPR
• and his personal connection to Poland, the birthplace of his father

This interview explores how fundamental science can lead to breakthroughs that may one day save lives.

Guest: Victor Ambros

Host: Sally Jastrzebska

Subscribe to TVP World for more interviews with global leaders in science, culture, and politics.

🔴 Watch our 24/7 livestream – https://youtube.com/live/m4mVcUReR6Y

Bringing you all the latest daily news and updates, TVP World is Poland’s first English-language channel where you can find world news as seen from the Polish perspective and the latest news from the CEE region. Follow us on Twitter, Facebook, Instagram.

https://tvpworld.com/
https://www.facebook.com/tvpworldcom

https://www.instagram.com/tvp_world/
https://www.threads.net/@tvp_world
https://bsky.app/profile/tvpworld.bsky.social

@tvpworld.com


https://t.me/tvp_world

#VictorAmbros #NobelPrize #NobelPrize2024

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x